Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D006152:Cyclic GMP / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology; D004745:Enkephalins / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006246:Harmaline / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D007608:Kainic Acid / Q000494:pharmacology; D009434:Neural Pathways / Q000502:physiology; D051381:Rats; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D004745:Enkephalins; D005680:gamma-Aminobutyric Acid; D006246:Harmaline; D006152:Cyclic GMP; D006220:Haloperidol; D001058:Apomorphine; D007608:Kainic Acid; D007538:Isoniazid; D004298:Dopamine